Pharmacological analysis of Drosophila melanogaster γ-secretase with respect to differential proteolysis of notch and APP

Molecular Pharmacology

Volumn 77, Issue 4, 2010, Pages 567-574

  Groth, Casper ^a   Alvord, W Gregory ^b   Quiñones, Octavio A ^b   Fortini, Mark E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; METALLOPROTEINASE; NOTCH RECEPTOR;

ARTICLE; DROSOPHILA MELANOGASTER; ENZYME INHIBITION; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; PROTEASE INHIBITORS; RECEPTORS, NOTCH;

EID: 77950197596     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.062471     Document Type: Article

References (47)

1. Barten DM, Guss VL, Corsa JA, Loo A, Hansel SB, Zheng M, Munoz B, Srinivasan K, Wang B, Robertson BJ, et al. (2005) Dynamics of β-amyloid reductions in brain, cerebrospinal fluid, and plasma of β-amyloid precursor protein transgenic mice treated with a γ-secretase inhibitor. J Pharmacol Exp Ther 312:635-643.
2. Best JD, Smith DW, Reilly MA, O'Donnell R, Lewis HD, Ellis S, Wilkie N, Rosahl TW, Laroque PA, Boussiquet-Leroux C, et al. (2007) The novel γ-secretase inhibitor N-[cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5- difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of Notch-related pathology in the Tg2576 mouse. J Pharmacol Exp Ther 320:552-558.
3. Capell A, Steiner H, Romig H, Keck S, Baader M, Grim MG, Baumeister R, and Haass C (2000) Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch. Nat Cell Biol 2:205-211.
4. Carmine-Simmen K, Proctor T, Tschäpe J, Poeck B, Triphan T, Strauss R, and Kretzschmar D (2009) Neurotoxic effects induced by the Drosophila amyloid-β peptide suggest a conserved toxic function. Neurobiol Dis 33:274-281.
5. Cole DC, Stock JR, Kreft AF, Antane M, Aschmies SH, Atchison KP, Casebier DS, Comery TA, Diamantidis G, Ellingboe JW, et al. (2009) (S)-N-(5- Chlorothiophene-2-sulfonyl)-β ,β-diethylalaninol a Notch-1-sparing γ-secretase inhibitor. Bioorg Med Chem Lett 19:926-929.
6. Coulson EJ, Paliga K, Beyreuther K, and Masters CL (2000) What the evolution of the amyloid protein precursor supergene family tells us about its function. Neurochem Int 36:175-184.
7. Dejaegere T, Serneels L, Schä fer MK, Van Biervliet J, Horré K, Depboylu C, Alvarez-Fischer D, Herreman A, Willem M, Haass C, et al. (2008) Deficiency of Aph-1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment. Proc Natl Acad Sci USA 105:9775-9780.
8. DeLean A, Munson PJ, and Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102.
9. Eggert S, Paliga K, Soba P, Evin G, Masters CL, Weidemann A, and Beyreuther K (2004) The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves α-, β-, γ-, and ε-like cleavages. Modulation of APLP-1 processing by N-glycosylation. J Biol Chem 279:18146-18156.
10. Fehon RG, Kooh PJ, Rebay I, Regan CL, Xu T, Muskavitch MA, and Artavanis-Tsakonas S (1990) Molecular interactions between the protein products of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila. Cell 61:523-534.
11. Fuwa H, Takahashi Y, Konno Y, Watanabe N, Miyashita H, Sasaki M, Natsugari H, Kan T, Fukuyama T, Tomita T, et al. (2007) Divergent synthesis of multifunctional molecular probes to elucidate the enzyme specificity of dipeptidic γ-secretase inhibitors. ACS Chem Biol 2:408-418.
12. Hébert SS, Serneels L, Dejaegere T, Horré K, Dabrowski M, Baert V, Annaert W, Hartmann D, and De Strooper B (2004) Coordinated and widespread expression of γ-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol Dis 17:260-272.
13. Hu Y and Fortini ME (2003) Different cofactor activities in γ-secretase assembly: evidence for a nicastrin-Aph-1 subcomplex. J Cell Biol 161:685-690.
14. Hu Y, Ye Y, and Fortini ME (2002) Nicastrin is required for γ-secretase cleavage of the Drosophila Notch receptor. Dev Cell 2:69-78.
15. Kopan R and Ilagan MX (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137:216-233.
16. Kulic L, Walter J, Multhaup G, Teplow DB, Baumeister R, Romig H, Capell A, Steiner H, and Haass C (2000) Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch. Proc Natl Acad Sci USA 97:5913-5918.
17. Lai MT, Chen E, Crouthamel MC, DiMuzio-Mower J, Xu M, Huang Q, Price E, Register RB, Shi XP, Donoviel DB, et al. (2003) Presenilin-1 and Presenilin-2 exhibit distinct yet overlapping γ-secretase activities. J Biol Chem 278:22475-22481.
18. Lewis HD, Pérez Revuelta BI, Nadin A, Neduvelil JG, Harrison T, Pollack SJ, and Shearman MS (2003) Catalytic site-directed γ-secretase inhibitors do not discriminate pharmacologically between Notch S3 and β-APP cleavages. Biochemistry 42:7580-7586.
19. Luo LQ, Martin-Morris LE, and White K (1990) Identification, secretion, and neural expression of APPL, a Drosophila protein similar to human amyloid protein precursor. J Neurosci 10:3849-3861.
20. McCarthy JV, Twomey C, and Wujek P (2009) Presenilin-dependent regulated intramembrane proteolysis and γ-secretase activity. Cell Mol Life Sci 66:1534-1555.
21. Milano J, McKay J, Dagenais C, Foster-Brown L, Pognan F, Gadient R, Jacobs RT, Zacco A, Greenberg B, and Ciaccio PJ (2004) Modulation of Notch processing by γ-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol Sci 82:341-358.
22. Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, Kaether C, Zheng H, Ghetti B, Haass C, et al. (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production. Proc Natl Acad Sci USA 99:8025-8030.
23. Morohashi Y, Kan T, Tominari Y, Fuwa H, Okamura Y, Watanabe N, Sato C, Natsugari H, Fukuyama T, Iwatsubo T, et al. (2006) C-terminal fragment of Presenilin is the molecular target of a dipeptidic γ-secretase-specific inhibitor DAPT (N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester). J Biol Chem 281:14670-14676.
24. Musa A, Lehrach H, and Russo VA (2001) Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development. Dev Genes Evol 211:563-567.
25. Nakajima M, Shimizu T, and Shirasawa T (2000) Notch-1 activation by familial Alzheimer's disease (FAD)-linked mutant forms of presenilin-1. J Neurosci Res 62:311-317.
26. Pinheiro JC and Bates DM (2002) Mixed-Effects Models in S- and S-Plus. Springer, New York.
27. Placanica L, Tarassishin L, Yang G, Peethumnongsin E, Kim SH, Zheng H, Sisodia SS, and Li YM (2009) Pen2 and presenilin-1 modulate the dynamic equilibrium of presenilin-1 and presenilin-2 γ-secretase complexes. J Biol Chem 284:2967-2977.
28. Pu J, Kreft AF, Aschmies SH, Atchison KP, Berkowitz J, Caggiano TJ, Chlenov M, Diamantidis G, Harrison BL, Hu Y, et al. (2009) Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide γ-secretase inhibitors. Bioorg Med Chem 17:4708-4717.
29. Rand MD, Grimm LM, Artavanis-Tsakonas S, Patriub V, Blacklow SC, Sklar J, and Aster JC (2000) Calcium depletion dissociates and activates heterodimeric Notch receptors. Mol Cell Biol 20:1825-1835.
30. Schroeter EH, Ilagan MX, Brunkan AL, Hecimovic S, Li YM, Xu M, Lewis HD, Saxena MT, De Strooper B, Coonrod A, et al. (2003) A presenilin dimer at the core of the γ-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc Natl Acad Sci USA 100:13075-13080.
31. Selkoe DJ (2001) Presenilin, Notch, and the genesis and treatment of Alzheimer's disease. Proc Natl Acad Sci USA 98:11039-11041.
32. Selkoe DJ and Wolfe MS (2007) Presenilin: running with scissors in the membrane. Cell 131:215-221.
33. Serneels L, Van Biervliet J, Craessaerts K, Dejaegere T, Horré K, Van Houtvin T, Esselmann H, Paul S, Schä fer MK, Berezovska O, et al. (2009) γ-secretase heterogeneity in the Aph-1 subunit: relevance for Alzheimer's disease. Science 324:639-642.
34. Shirotani K, Edbauer D, Prokop S, Haass C, and Steiner H (2004) Identification of distinct γ-secretase complexes with different APH-1 variants. J Biol Chem 279:41340-41345.
35. Steiner H, Winkler E, and Haass C (2008) Chemical cross-linking provides a model of the γ-secretase complex subunit architecture and evidence for close proximity of the C-terminal fragment of presenilin with APH-1. J Biol Chem 283:34677-34686.
36. Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, Takahashi Y, Thinakaran G, and Iwatsubo T (2003) The role of presenilin cofactors in the γ-secretase complex. Nature 422:438-441.
37. Tanii H, Jiang J, Fukumori A, Tagami S, Okazaki Y, Okochi M, and Takeda M (2006) Effect of valine on the efficiency and precision at S4 cleavage of the Notch-1 transmembrane domain. J Neurosci Res 84:918-925.
38. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL, Borchelt DR, and Sisodia SS (1997) Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem 272:28415-28422.
39. Tien AC, Rajan A, and Bellen HJ (2009) A Notch updated. J Cell Biol 184:621-629.
40. Tomita T, Tanaka S, Morohashi Y, and Iwatsubo T (2006) Presenilin-dependent intramembrane cleavage of ephrin-B1. Mol Neurodegener 1:2.
41. van Es JH, van Gijn ME, Riccio O, van den Born M, Vooijs M, Begthel H, Cozijnsen M, Robine S, Winton DJ, Radtke F, et al. (2005) Notch/γ- secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435:959-963.
42. Vingtdeux V, Hamdane M, Gompel M, Bégard S, Drobecq H, Ghestem A, Grosjean ME, Kostanjevecki V, Grognet P, Vanmechelen E, et al. (2005) Phosphorylation of amyloid precursor carboxy-terminal fragments enhances their processing by a γ-secretase-dependent mechanism. Neurobiol Dis 20:625-637.
43. Vingtdeux V, Hamdane M, Loyens A, Gelé P, Drobeck H, Bégard S, Galas MC, Delacourte A, Beauvillain JC, Buée L, et al. (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J Biol Chem 282:18197-18205.
44. Wolfe MS, Citron M, Diehl TS, Xia W, Donkor IO, and Selkoe DJ (1998) A substrate-based difluoro ketone selectively inhibits Alzheimer's γ-secretase activity. J Med Chem 41:6-9.
45. Xia W, Zhang J, Ostaszewski BL, Kimberly WT, Seubert P, Koo EH, Shen J, and Selkoe DJ (1998) Presenilin 1 regulates the processing of β-amyloid precursor protein C-terminal fragments and the generation of amyloid β-protein in endoplasmic reticulum and Golgi. Biochemistry 37:16465-16471.
46. Yang T, Arslanova D, Gu Y, Augelli-Szafran C, and Xia W (2008) Quantification of γ-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein. Mol Brain 1:15.
47. Zhang DM, Levitan D, Yu G, Nishimura M, Chen F, Tandon A, Kawarai T, Arawaka S, Supala A, Song YQ, et al. (2000) Mutation of the conserved N-terminal cysteine (Cys92) of human presenilin 1 causes increased Aβ42 secretion in mammalian cells but impaired Notch/lin-12 signalling in C. elegans. Neuroreport 11:3227-3230.